BioVeris Corporation

BioVeris Launches New Products for Life Sciences

Published in Lab Business Week, March 11th, 2007

BioVeris Corporation (NASDAQ:BIOV) announced that it has introduced for sale eight new products for use in life science research. These new products are focused on meeting the increasing demand among pharmaceutical and biotechnology companies for a means to measure potential immune response to protein-based therapeutics that are in development.

Two of the new products are pharmacodynamic biomarkers designed to measure cytokine levels that may be elevated in response to a drug treatment. These cytokine products detect human IL-2 and TNF-alpha, molecules that are up- regulated in inflammation and in many immune responses. Six of the new products can be used for...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Business Week

Source: Lab Business Week (2007-03-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry